Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Abivax SA - American Depositary Shares (NQ:ABVX)

113.61 +2.79 (+2.52%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 18, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	968,200
Open	113.99
Bid (Size)	113.85 (200)
Ask (Size)	114.30 (100)
Prev. Close	110.82
Today's Range	112.01 - 117.72
52wk Range	4.770 - 138.49
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Abivax to be Added to Nasdaq Biotechnology Index

Today 16:05 EST

From Abivax

Via GlobeNewswire

The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains

Today 10:44 EST

The financial markets are witnessing a historic "Great Rotation" this December, as the era of defensive posturing and mega-cap concentration appears to be giving way to a broad-based growth rally....

Via MarketMinute

Performance

YTD	+1458.4%	+1458.4%
1 Month	-0.2%	-0.2%
3 Month	+36.4%	+36.4%
6 Month	+1803.0%	+1803.0%
1 Year	+1356.5%	+1356.5%

More News

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

December 17, 2025

From Abivax

Via GlobeNewswire

Abivax Presents Third Quarter 2025 Financial Results

December 15, 2025

From Abivax

Via GlobeNewswire

2 Under-the-Radar Stocks That Have Soared This Year ↗

December 09, 2025

Via The Motley Fool

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗

December 09, 2025

Via The Motley Fool

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗

December 09, 2025

Via The Motley Fool

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗

December 09, 2025

Via The Motley Fool

6 Healthcare Stocks With Strong Upward Momentum ↗

November 18, 2025

Via Benzinga

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗

November 17, 2025

Via The Motley Fool

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗

November 17, 2025

Via The Motley Fool

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗

November 17, 2025

Via The Motley Fool

This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗

November 17, 2025

Via The Motley Fool

This Brinker International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

November 06, 2025

Via Benzinga

Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis

November 03, 2025

From Abivax

Via GlobeNewswire

Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday ↗

October 09, 2025

Via Benzinga

AMD To Rally More Than 47%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 07, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

Why Is Abivax Stock Trading Higher On Monday? ↗

October 06, 2025

Via Benzinga

Top 1% Biotech Abivax Surges On 'Compelling' Results In A Highly Watched Disease ↗

October 06, 2025

Via Investor's Business Daily

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior Inadequate Response to Advanced Therapies

October 06, 2025

From Abivax

Via GlobeNewswire

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data

October 05, 2025

From Abivax

Via GlobeNewswire

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting

September 29, 2025

From Abivax

Via GlobeNewswire

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting

September 23, 2025

From Abivax

Via GlobeNewswire

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

September 12, 2025

From Abivax

Via GlobeNewswire

Frequently Asked Questions

Is Abivax SA - American Depositary Shares publicly traded?

Yes, Abivax SA - American Depositary Shares is publicly traded.

What exchange does Abivax SA - American Depositary Shares trade on?

Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Abivax SA - American Depositary Shares?

The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market

What is the current price of Abivax SA - American Depositary Shares?

The current price of Abivax SA - American Depositary Shares is 113.61

When was Abivax SA - American Depositary Shares last traded?

The last trade of Abivax SA - American Depositary Shares was at 12/18/25 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.